XTL Biopharmaceuticals Ltd.

Foreign Filer Report • Feb 22, 2016

_________ false

C002��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD10174Corporation no: 520039470Stock Exchange/Market: NASDAQ CM1996380HaCharoshet st 5 , Ra'anana 43656 , Israel ,Tel: 09-9557080 , Fax: 09-9519708E.mail address: ir@xtlbio.comReported via MAGNA: 22/02/2016              Time of broadcast: 15:42 15:09:12

Company site:		www.xtlbio.com

Reference: 2016-02-032356

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on XTL BIOPHARMACEUTICALS RECEIVES EUROPEAN MEDICINES AGENCY�S SME STATUS
2016_02_22_XTLB_6-K_SME_Status_CLEAN_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 31/01/2016
- - -
Name of the Signatory: : Kestenbaum David , Position of Signatory in the reporting corporation: Chief Financial Officer , Name of Employer Company: .
Medinat hayehudim st Telephone: 09-9557080 , Facsimile: 09-9519727 , E-mail: davidk@xtlbio.com 2